Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
New blood biomarkers enable differentiation between the main neurodegenerative diseases that cause dementia
The study identifies protein signatures specific to Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and integrates them into a single quantitative biomarker panel.
The evolutionary cost of fertility explains why disease-related genetic variants persist
The results offer a new evolutionary perspective on human health and help explain why many genetic variants associated with common diseases have been maintained throughout evolution
The image of a decade: 10,000 MRI scans to understand Alzheimer’s at the BBRC
The BBRC reaches a historic milestone that reflects years of collective effort, cutting-edge technology and an open, collaborative science model.
BBRC takes part in AAIC 2026 with its largest representation to date
The centre’s research staff will present 7 talks and 25 scientific posters at the world’s largest Alzheimer’s conference.
We strengthen our research in Molecular Epidemiology and Data Science with a New Group Led by Dr. Natàlia Vilor-Tejedor
The addition brings the total number of groups at the research center to nine and strengthens its capabilities in molecular epidemiology, biostatistics, and data science as applied to Alzheimer’s disease and brain health
We analyze the relationship between the reproductive history and the preclinical stages of Alzheimer’s disease
The study provides preliminary evidence that the number of births may only influence cognitive decline in women who already have high levels of β-amyloid protein in their brain
Blood biomarkers can rule out Alzheimer’s disease in people with subjective memory complaints
The study shows that certain blood biomarkers can help rule out the presence of Alzheimer’s disease pathology in people with subjective memory complaints, although lumbar puncture remains necessary to confirm the diagnosis.
Biomarkers consolidate their key role in the future of Alzheimer’s and neurodegenerative disease research
Around 100 researchers have taken part in a new edition of the Biomarkers Course organized by BBRC together with the University College London and the University of Gothenburg.
The Barcelonaβeta Brain Research Center creates a new research group in AI and Health Data led by Dr. Joaquín Dopazo
With this addition, the BBRC consolidates eight research groups and strengthens its capacity in artificial intelligence and biomedical data analysis applied to neurodegenerative diseases.
